Medical journals can promote the reporting of gender-related information by requiring a structured presentation of such information when results of clinical trials are published. Data should be analyzed to see if women respond differently from men to drug therapy. Gender should be a point of discussion in the concluding comments of published reports. If women are under-represented in the trial, this limitation should be discussed. If differences between men and women are discovered, they should be described.
Heart disease is the leading cause of death and disability among Canadian women.
Seven of the 43 clinical trials were funded by an agency with a policy to enhance the inclusion of women in clinical trials of drug therapy for which they are a target market. However, these trials did not improve the representation of women, nor the reporting of gender-related results. According to Statistics Canada, the number of seniors with dementia is expected to triple to 800,000 by the year 2031. The Rotman Institute is regarded as one of the world's leading brain research centres, alongside Harvard University and Cambridge University, England. The Rotman Institute is one of only three brain research centres in the world selected by the McDonnell Foundation to develop a research program in cognitive rehabilitation.